Neurogene Inc. 4

Keith Woods received a fully vested stock option award for 7,700 shares of Neurogene Inc. common stock at a $42.59 exercise price.

On June 14, 2024, Keith Woods received a fully vested stock option grant from Neurogene Inc. to purchase 7,700 shares of common stock at an exercise price of $42.59 per share, representing an option award with a notional value of approximately $328,000; upon exercise, the option would result in ownership of 7,700 shares of common stock. This Form 4/A is an administrative amendment re-filing the original June 17, 2024 Form 4 under the correct CIK number for the reporting person and does not reflect any change in the economic terms of the award.

Filing Facts

CIK

1404644

Ticker

NGNE

Form

4

Source Type

sec

Accession

0001996804-26-000010

Alert Tier

5